EMJ GOLD - European Medical Journal

Continue

Pharma News, Views & Analysis

Filter Advertise With Us
a lighthouse shining on a group of people

Reaching healthcare professionals with the latest advances

The journey from approval to patient can be convoluted. How can pharma teams communicate the latest advances to busy healthcare professionals?

AZ’s Stefan Woxström on preparing healthcare systems for the future

Stefan Woxström, Senior Vice President Europe and Canada, AstraZeneca, talks about the need for future-proofing healthcare systems, incentivising innovation and reimbursement.

Does pharma have the power to turn back time?

Finding a way to combat the negative effects of ageing could save healthcare systems millions. Learn whether ageing could be the next big pharma market to take the world by storm.

Roundtable: How can pharma close the gender health gap?

Robyn Widenmaier (GSK) and Tabetha Sundin (AstraZeneca) discuss whether bids to improve gender parity could be the ticket to change in women’s health.

Get ready for Gen Z doctors

A new generation of doctors is making their way into the workforce, but is the pharmaceutical industry ready to change its tactics to engage these younger HCPs?

Has medical affairs reached 'strategic pillar' standing?

The value of medical affairs is not up for debate, but are companies allocating enough time and resources to make it the strategic function it can be?

VPAG: the UK's ticket to pharma superpower status?

A deal ends months of wrangling between the UK government and the ABPI, but what will it mean for the industry and the UK’s bid to become a life sciences superpower?

Roundtable: Was it worth the risk?

With compliance and regulatory hoops to jump through, medical affairs teams can be reluctant to try new tactics. This roundtable uncovers their relationship with risk and asks what the future holds.